Navigation Links
New Cancer Drug Hits the Mark

A new cancer drug is being hailed by researchers for its ability to target cancer cells and keep them from multiplying//.

The drug being called ON01910 works by interfering with a molecule known as Plk1, which cancer cells need in order to divide and multiply. This molecule is found in higher numbers in cancerous tumors, and people with poorer cancer survival rates tend to have especially high amounts.

The drug was tested on 94 different types of human cancers in the laboratory both individually and in combination with other cancer drugs. The drug was able to inhibit cell division and thus hasten the death of the cancerous cells. It also appeared to be safe.

The drug is being investigated by researchers from different parts of the world who are testing the drug in up to 56 cancer patients with advanced or terminal disease to see how it works in people.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... ... A recent survey by the Midwest Business Group on Health (MBGH) ... the free preventive care benefits available to them as part of the Affordable Care ... and private employers, MBGH found that only 10% of large employers are aware of ...
(Date:5/5/2016)... Dubuque, IA (PRWEB) , ... May 05, 2016 ... ... his insurance agency’s ongoing community enrichment program serving families of greater Dubuque, IA. ... area’s active duty, reserve and honorably discharged veterans. Donations to Veteran’s Freedom Center ...
(Date:5/5/2016)... ... May 05, 2016 , ... A ... found that more than 40 percent of participating fifth-grade students already have or ... Allergy and Asthma Clinical Research in the Division of Pulmonary, Allergy and Critical ...
(Date:5/5/2016)... YORK (PRWEB) , ... May 05, 2016 , ... TIME ... swimming safety – today announced a new partnership to reach nearly 1 million children ... happen in an instant and is the leading cause of accidental death in children ...
(Date:5/5/2016)... ARIZ. (PRWEB) , ... May 05, 2016 , ... ... president Jennifer Drago presented a talk highlighting the organization’s successful Care Transitions ... in Chicago. , The talk was titled “Minimizing Costs in the Post-Acute Environment ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... First Quarter 2016 Highlights , Generated Cash ... Flow") of $13.6 million for the first quarter of ... for the first quarter of 2016; , Paid ...
(Date:5/4/2016)... -- According to market research "Global Computed Tomography ... 2022 - Industry Insights by Slice Type (High, Mid and ... P&S Market Research, the global computed tomography market ... expected to grow at a CAGR of 5.0% during 2016-2022. ... expected to witness the faster growth, CAGR of 5.3%, during ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
Breaking Medicine Technology: